Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Authors :: Joern Toedling
Cornelia Eckert
Annabell Szymansky
MJ Witthauer
M Fischer
L Heukamp
Patrick Hundsdoerfer
Overath
K Schönbeck
JH Schulte
J Heukmann
Annika Winkler
F Hertwig
M.J. Pogodzinski
R Menon
Angelika Eggert
Source :: Klinische Pädiatrie.
Publication Year :: 2018
Publisher :: Georg Thieme Verlag KG, 2018.

Subjects :: Chromosomal breakpoint
Neuroblastoma
Cancer research
medicine
Biology
medicine.disease
Minimal residual disease

Full Text Access

Tools